More Business Wire
View Older Stories View Newer Stories-
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
-
KKR to Launch Tender Offer for Forum Engineering
-
Almirall’s 2025 9M Results
-
emeis: Refinancing and Extension of Debt Maturity
-
Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
-
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
-
It’s the Season for Savings: Amazon’s Black Friday Week and Cyber Monday Deal Events Offer Deep Discounts on Customer-Favorite Brands from November 20 through December 1
-
mimik Ignites Abu Dhabi Edge AI Revolution—New Joint Venture Builds a Global Blueprint for Industrial Edge Agentic AI
-
Tokyo Metropolitan Government Selects Multi-Use Case Implementation Project Featuring SkyDrive and Joby Aviation Aircraft for “eVTOL Implementation Project (Phase I)"
-
e.l.f. Lands at ULTA Beauty Mexico, Expanding Accessibility to the Best of Beauty for Every Eye, Lip, and Face
-
Kirin: Development of a Fermented Ingredient Derived from Coffee Cherries to Enhance Body and Aroma Contributing to the Sustainability of Coffee Farms, Reduction of Environmental Impact, and Addressin
-
AUTEL Powers High-Speed EV Charging Station at Bangkok’s Central World
-
Kaneka Expands Global Reach with i-ED COIL™ Launch in Europe
-
Foundation for the Development of Western Syria Urges Concrete Commitments from Jolani Regime Ahead of White House Meeting
-
Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High R
-
Virion Therapeutics Reports Progress Towards HBV Functional Cure with Sustained and Continued HBsAg Declines up to One Year After a Single VRON-0200 Dose From its Phase 1b Study at AASLD’s The Liver
-
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial
-
Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hy
-
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
-
Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Life Insurance Segment
-
Stepful Keeps Healthcare Training Free for Military Families Amid Government Shutdown
-
Anumana Advances AI-Driven Cardiovascular Science with Late-Breaking Heart Failure Study and Multiple Abstracts at AHA 2025
-
Teledyne FLIR Defense Names Riyadh-Based Managing Director for Middle East and North Africa
-
Workers at Aimbridge-operated hotels in Los Angeles and Philadelphia strike during event-filled weekend, UNITE HERE reports
-
In Response to a Broader FDA Investigation, ByHeart Initiates a Voluntary Recall of Two Batches of Infant Formula
-
Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at Amer
-
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
-
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
-
Real Reaches Settlement in Principle in Litigation With Former CFO
-
FIS Launches Innovative Asset Servicing Management Suite to Unlock Operational Efficiency Across Asset Servicing
-
Groundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions
-
Westinghouse and Hungary Establish Landmark Nuclear Fuel Partnership
-
American Gridwork Partners Acquires PMT Site to Accelerate Modernization of American’s National Grid Infrastructure Network
-
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
-
Kunming Is Becoming China’s Top Destination City for Inbound Consumption
-
OMRON Releases the “Medium-Term Roadmap SF 2nd Stage”
-
Sandra Sanderson of Empire Company Limited/Sobeys Inc. and Catherine Roche at BMO Named Top Winners at 2025 CMA Awards
-
Phoenix Education Partners Schedules Fourth Quarter and Full Year Earnings Conference Call
-
Lomiko Metals Announces Industry & Corporate and Financing Update
-
US Metro Bancorp Completes $31.9 Million Subordinated Note Capital Raise and Redemption of $16.0 Million Subordinated Note
-
Gizmo Medical Redefines OEM Partnerships with Fully Customized Surgical Systems
-
Magellan Aerospace Announces Quarterly Dividend
-
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Fidium and Ciena Supercharge Connectivity in Texas Triangle Megaregion
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Streetlight Ventures, Launchpad Capital to Launch Restaurant & Hospitality-Focused SPAC
-
Westwater Resources Announces Strategic Update
-
TomaGold Announces Proposed Private Placement
-
Waterous Energy Fund Announces Disposition of Shares of Strathcona Resources Ltd.
-
Momentus Grants Inducement Awards to Two New Employees
